We are live on ! Find out more
ATHE icon

Alterity Therapeutics

13 hedge funds and large institutions have $149K invested in Alterity Therapeutics in 2024 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 1

261% more capital inflows, than outflows

Capital inflows: $70.6K | Capital outflows: $19.6K

30% more funds holding

Funds holding: 10 → 13 (+3)

0.4% more ownership

Funds ownership: 0.89% → 1.29% (+0.4%)

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

Holders
13
Holders Change
+3
Holders Change %
+30%
% of All Funds
0.19%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
1
Reduced
2
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

ATHE Hedge Fund Activity: Q3 2024 in Review

13 of the 6,991 institutional investors tracked by Wall St. Rank reported a position in Alterity Therapeutics (ATHE) for Q3 2024, worth a combined $149K — up 5.5% from $141K a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new ATHE positions and 1 closed out — a net gain of 3 holders — while 1 added to existing stakes and 2 trimmed.

The largest buyer was HB Wealth Management, opening a new position worth an estimated $35K. The largest seller was Susquehanna International Group, cutting an estimated $13.8K.

  • 13 institutional investors held Alterity Therapeutics (ATHE) as of Q3 2024, up from 10 in Q2 2024.
  • Funds reported $149K of Alterity Therapeutics stock for Q3 2024, up 5.5% quarter-over-quarter.
  • 4 funds opened new Alterity Therapeutics positions in Q3 2024 and 1 closed out, a net change of +3 holders.
  • The largest Alterity Therapeutics buyer in Q3 2024 was HB Wealth Management, an estimated $35K added.
  • The largest Alterity Therapeutics seller in Q3 2024 was Susquehanna International Group, an estimated $13.8K sold.

Based on aggregated 13F filings for Q3 2024.